Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

NeuroPace Q2 EPS $(0.26) Misses $(0.23) Estimate, Sales $23.52M Beat $23.09M Estimate

Author: Benzinga Newsdesk | August 12, 2025 03:08pm
NeuroPace (NASDAQ:NPCE) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.23) by 15.56 percent. This is unchanged from the same period last year. The company reported quarterly sales of $23.52 million which beat the analyst consensus estimate of $23.09 million by 1.88 percent. This is a 22.14 percent increase over sales of $19.26 million the same period last year.

Posted In: NPCE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist